Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home › Products & Services › Infectious Diseases › Laboratories and Reference Facilities › Virus Reference Department (VRD) ›Blood Borne Viruses Unit (BBVU) ›  BBVU Publications
Printer friendly page (opens in new window)

BBVU Publications

2007 - 2009

  • Persistent carriage of hepatitis E virus in patients with HIV infection. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. N Engl J Med. 2009 Sep 3;361(10):1025-7.
  • Hepatitis B virus reactivation in a large haemodialysis unit: virological and infection control issues. Bhattacharya S, Ijaz S, Ratnaraja N, Smith S, Osman H, Boxall E. J Clin Virol. 2009 Sep;46(1):101-3.
  • Indigenous hepatitis E virus infection in England: more common than it seems. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. J Clin Virol. 2009 Apr;44(4):272-6.
  • Hepatitis E: an emerging infection in developed countries. Dalton HR, Bendall R, Ijaz S, Banks M. Lancet Infect Dis. 2008 Nov;8(11):698-709.
  • Of pigs and pregnancy. Andersson MI, Hughes J, Gordon FH, Ijaz S, Donati M. Lancet. 2008 Sep 27;372(9644):1192.
  • Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases. Buchler T, Dubash S, Lee V, Chilton D, Cartledge J, Isaacson P, Tedder RS, Lee SM. AIDS. 2008 Aug 20;22(13):1685-7.
  • Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples. Daniel HD, Grant PR, Garson JA, Tedder RS, Chandy GM, Abraham P. Diagn Microbiol Infect Dis. 2008 Aug;61(4):415-20.
  • Hepatitis E autochthonous infection in chronic liver disease. Lockwood GL, Fernandez-Barredo S, Bendall R, Banks M, Ijaz S, Dalton HR. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):800-3.
  • Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, Farrington L, Hamad N, Sieberhagen C, Ellis V, Mitchell J, Hussaini SH, Banks M, Ijaz S, Bendall RP. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):784-90.
  • Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant. Sloan RD, Ijaz S, Moore PL, Harrison TJ, Teo CG, Tedder RS. Antivir Ther. 2008;13(3):439-47.
  • Correlation between hepatitis B genotypes, 1896 precore mutation, virus loads and liver dysfunction in an Indian population. Vivekanandan P, Bissett S, Ijaz S, Teo CG, Sridharan G, Raghuraman S, Daniel HD, Kavitha ML, Daniel D, Chandy GM, Abraham P. Indian J Gastroenterol. 2008 Jul-Aug;27(4):142-7.
  • Outbreaks of hepatitis A in England and Wales associated with two co-circulating hepatitis A virus strains. Ngui SL, Granerod J, Jewes LA, Crowcroft NS, Teo CG; 2002 Hepatitis A Outbreaks Investigation Network. J Med Virol. 2008 Jul;80(7):1181-8.
  • Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy. Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, Naoumov NV. J Med Virol. 2008 Jul;80(7):1160-70.
  • HepSEQ--an integrated hepatitis B epidemiology and sequence analysis platform. Myers R, Gnaneshan S, Ijaz S, Tedder R, Ramsay M, Green J; HepSEQ Steering Committee. Euro Surveill. 2008 May 8;13(19). pii: 18866.
  • Hepatitis C virus window-phase infections: closing the window on hepatitis C virus. Tuke PW, Grant PR, Waite J, Kitchen AD, Eglin RP, Tedder RS. Transfusion. 2008 Apr;48(4):594-600.
  • Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. J Med Virol. 2008 Jan;80(1):95-101.
  • Hepatitis E in England and Wales. Lewis HC, Boisson S, Ijaz S, Hewitt K, Ngui SL, Boxall E, Teo CG, Morgan D. Emerg Infect Dis. 2008 Jan;14(1):165-7.
  • Non-A hepatitis B virus genotypes in antenatal clinics, United Kingdom. Dervisevic S, Ijaz S, Chaudry S, Tedder RS. Emerg Infect Dis. 2007 Nov;13(11):1689-93.
  • The role of hepatitis E virus testing in drug-induced liver injury. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, Remnarace R, Ijaz S, Hussaini SH, Bendall RP. Aliment Pharmacol Ther. 2007 Nov 15;26(10):1429-35.
  • Transmission of hepatitis B virus (genotype E) in a haemodialysis unit. Ramalingam S, Leung T, Cairns H, Sibley P, Smith M, Ijaz S, Tedder R, Zuckerman M. J Clin Virol. 2007 Oct;40(2):105-9.
  • Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. J Med Virol. 2007 Oct;79(10):1464-71.
  • Passage from India: an outbreak of hepatitis B linked to a patient who acquired infection from health care overseas. Harling R, Turbitt D, Millar M, Ushiro-Lumb I, Lacey S, Xavier G, Pope J, Ijaz S, Teo CG. Public Health. 2007 Oct;121(10):734-41.
  • Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-alpha 2b and ribavirin. Buckton AJ, Kulasegaram R, Ngui SL, Fisher M, James R, Rangarajan S, Teo CG. J Clin Virol. 2007 Sep;40(1):60-3.
  • Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis. Ghafur A, Raza M, Labbett W, Chawla A, Smith C, Ngui SL, Davenport A, Geretti AM. Nephrol Dial Transplant. 2007 Sep;22(9):2640-4.
  • Salivary human herpesvirus 8 shedding in renal allograft recipients with Kaposi's sarcoma. Al-Otaibi LM, Ngui SL, Scully CM, Porter SR, Teo CG. J Med Virol. 2007 Sep;79(9):1357-65.
  • Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. Fryer JF, Delwart E, Bernardin F, Tuke PW, Lukashov VV, Baylis SA. J Gen Virol. 2007 Aug;88(Pt 8):2162-7.
  • Investigation of hepatitis C transmission in a UK haemodialysis unit: possible role of Schribner shunt vascular access device. Webster DP, Jeffery KJ, Cann K, Teo CG, Ngui SL, Mason P, Bowler IC. J Hosp Infect. 2007 Aug;66(4):391-2.
  • Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss. Ferns RB, Naoumov NV, Gilson RJ, Tedder RS. J Clin Virol. 2007 Jul;39(3):199-204.
  • Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. Jalal H, Bibby DF, Bennett J, Sampson RE, Brink NS, MacKinnon S, Tedder RS, Ward KN. J Clin Microbiol. 2007 Jun;45(6):1690-6.
  • Cytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utility. Edwards SG, Grover D, Scott C, Tedder RS, Pillay D, Copas A, Miller RF. Int J STD AIDS. 2007 May;18(5):321-3.
  • Autochthonous hepatitis E in southwest England. Dalton HR, Thurairajah PH, Fellows HJ, Hussaini HS, Mitchell J, Bendall R, Banks M, Ijaz S, Teo CG, Levine DF. J Viral Hepat. 2007 May;14(5):304-9.
  • Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. Stene-Johansen K, Tjon G, Schreier E, Bremer V, Bruisten S, Ngui SL, King M, Pinto RM, Aragonès L, Mazick A, Corbet S, Sundqvist L, Blystad H, Norder H, Skaug K. J Med Virol. 2007 Apr;79(4):356-65.
  • Locally acquired hepatitis E in chronic liver disease. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Lancet. 2007 Apr 14;369(9569):1260.
  • HepSEQ: International Public Health Repository for Hepatitis B. Gnaneshan S, Ijaz S, Moran J, Ramsay M, Green J. Nucleic Acids Res. 2007 Jan;
  • The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. Leong HN, Tuke PW, Tedder RS, Khanom AB, Eglin RP, Atkinson CE, Ward KN, Griffiths PD, Clark DA. J Med Virol. 2007 Jan;79 (1):45-51.


Last reviewed: 6 October 2009